Evidence‐based guidelines for the use of immunologic tests: Anticentromere, Scl‐70, and nucleolar antibodies
Top Cited Papers
- 3 June 2003
- journal article
- guideline
- Published by Wiley in Arthritis Care & Research
- Vol. 49 (3) , 399-412
- https://doi.org/10.1002/art.11113
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in sclerodermaArthritis & Rheumatism, 2000
- Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosisArthritis & Rheumatism, 2000
- Longitudinal Study of Anticentromere and Antitopoisomerase-I IsotypesClinical Immunology and Immunopathology, 1995
- Users' Guides to the Medical LiteratureJAMA, 1994
- Autoantibodies to topoisomerase I (Scl-70): Analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assayClinical Immunology and Immunopathology, 1990
- Marker antibodies in scleroderma and polymyositis: Clinical associationsClinical Rheumatology, 1989
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- Autoantibody to RNA polymerase I in scleroderma sera.Journal of Clinical Investigation, 1987
- Anticentromere antibody in localized sclerodermaJournal of the American Academy of Dermatology, 1986
- Serological markers in progressive systemic sclerosis: clinical correlations.Annals of the Rheumatic Diseases, 1983